Scientist in In Vivo Pharmacology and Cancer Research

Are you passionate about making a difference and eager to contribute to the development of advanced animal models within targeted radionuclide therapy? Then Minerva Imaging might be your new place of work!
As a Research Scientist at Minerva Imaging, you will become responsible for designing, planning, and executing in vivo studies, primarily in the field of oncology. To thrive in this role, you should possess a deep understanding of disease models and have the ability to design and interpret in vivo pharmacology studies. You are a structured individual with a strong sense of ownership, setting high standards for both study execution and data delivery. A positive attitude and an ability to adapt to changing priorities and deadlines are key.

You will join our Small Animal Pharmacology Department, which consists of scientists and technicians, and your daily responsibilities will include the following tasks:

• Plan and conduct animal studies in rodents, focusing on oncology and targeted radionuclide therapy (e.g., evaluating drug toxicity, efficacy, and biodistribution).
• Write study protocols, analyze and interpret data, and report study results.
• Communicate effectively with internal and external stakeholders, from technicians to Sponsor representatives.
• Contribute to the development and establishment of new animal models, primarily within oncology, in collaboration with scientists and technicians.
• Actively participate in the daily work within the animal facility.

Qualifications:
While experience from academia or industry is highly valued, we encourage you to apply if you are eager to learn.

• A MSc or a PhD in biology, pharmacology, veterinary medicine, or a related field. A background in in vivo pharmacology (rodents) is preferred.
• Hands-on experience with rodent animal techniques (e.g. handling, different dosing regimens and surgical techniques).
• Previous work experience with oncology animal models, radioactivity and/or molecular imaging techniques is an advantage.
• Diploma in laboratory animal science equivalent to FELASA category AD is required.
• Ability to plan, execute, and report internal and external projects in collaboration with scientists.

In addition to these qualifications, strong communication skills are critical. Most of our communication is in English, so proficiency in both written and spoken English is essential.

Minerva offers:
Minerva Imaging offers a combined compensation package with a base salary, pension and a company wide bonus program. We believe in creating an agile working environment, so we have flexible working options including the option of working from home. We care about our employees’ well-being and offer health insurance and a quality conscious lunch scheme and monthly social activities.

We are an informal organization with a strong focus on open and honest communication. We value humour and a natural care for one another.

Application:
Please submit your application to us no later than 30 th of October 2024. The application must include a motivated cover letter and a CV addressing the listed qualifications. Applications will be evaluated continuously.

If you have questions regarding the position, please contact Trine Bjørnbo Engel at +4527269877 or at [email protected].

About Minerva Imaging:
Minerva Imaging is a scientifically driven and integrated CRO and CDMO specialized in targeted radionuclide therapies. We focus on the use of advanced animal models within oncology, cardiovascular diseases, and in vivo molecular imaging for translational research and drug development.

We engage with our sponsors to understand their scientific questions and discuss how our methods and capabilities can provide answers. Our facility located in Ølstykke, Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development, and manufacturing services.

Minerva Imaging is an equal opportunity employer, and we encourage candidates of all backgrounds and experiences to apply.

Follow us on LinkedIn for the latest news updates or visit www.minervaimaging.com for more information.

Department: Small animal pharmacology & Molecular oncology

Deadline: 30 October 2024

Location: 3650, Ølstykke, Denmark